MX2022005919A - Masa liofilizada en vial de pared recta. - Google Patents

Masa liofilizada en vial de pared recta.

Info

Publication number
MX2022005919A
MX2022005919A MX2022005919A MX2022005919A MX2022005919A MX 2022005919 A MX2022005919 A MX 2022005919A MX 2022005919 A MX2022005919 A MX 2022005919A MX 2022005919 A MX2022005919 A MX 2022005919A MX 2022005919 A MX2022005919 A MX 2022005919A
Authority
MX
Mexico
Prior art keywords
straight
lyophilized cake
vial
walled vial
walled
Prior art date
Application number
MX2022005919A
Other languages
English (en)
Inventor
Ii Donald D Evans
Mayur Patel
Lee J Stimpson
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Publication of MX2022005919A publication Critical patent/MX2022005919A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/065—Rigid ampoules, e.g. glass ampoules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1412—Containers with closing means, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1406—Septums, pierceable membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un sistema que incluye un vial y métodos de su uso para proporcionar una masa liofilizada removible del vial sin fractura o rompimiento.
MX2022005919A 2019-11-18 2020-11-05 Masa liofilizada en vial de pared recta. MX2022005919A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962937061P 2019-11-18 2019-11-18
PCT/US2020/059074 WO2021101720A1 (en) 2019-11-18 2020-11-05 Lyophilized cake in straight-walled vial

Publications (1)

Publication Number Publication Date
MX2022005919A true MX2022005919A (es) 2022-06-22

Family

ID=73643341

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022005919A MX2022005919A (es) 2019-11-18 2020-11-05 Masa liofilizada en vial de pared recta.

Country Status (10)

Country Link
US (1) US20220409484A1 (es)
EP (1) EP4061303A1 (es)
JP (1) JP2023503000A (es)
KR (1) KR20220100681A (es)
CN (1) CN114727904A (es)
AU (1) AU2020388532A1 (es)
BR (1) BR112022009082A2 (es)
CA (1) CA3157405A1 (es)
MX (1) MX2022005919A (es)
WO (1) WO2021101720A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11806716B2 (en) 2019-12-20 2023-11-07 Schott Pharma Ag & Co. Kgaa Glass container comprising a glass bottom with improved properties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1600977A (es) * 1968-12-27 1970-08-03
ZA953703B (en) * 1994-05-10 1996-01-10 American Home Prod Modified live BRSV vaccine
BRPI0518070A (pt) * 2004-10-27 2008-10-28 Glaxosmithkline Biolog Sa processo para preparar um material lioflizado, e, aparelho adequado para uso no mesmo
JP2012125436A (ja) * 2010-12-16 2012-07-05 Otsuka Pharmaceut Factory Inc バイアル
US8821852B2 (en) * 2010-12-22 2014-09-02 Intervet Inc. Vaccines with live bacterial isolates for systemic administration
BR112013027057A2 (pt) * 2011-04-21 2020-08-11 Trustees Of Tufts College composições e métodos para a estabilização de agentes ativos
EP2934420B1 (en) * 2012-12-21 2018-02-07 Peter Skufca Primary packaging for storage and/or administration of medical or pharmaceutical compounds

Also Published As

Publication number Publication date
EP4061303A1 (en) 2022-09-28
KR20220100681A (ko) 2022-07-15
CA3157405A1 (en) 2021-05-27
CN114727904A (zh) 2022-07-08
US20220409484A1 (en) 2022-12-29
WO2021101720A1 (en) 2021-05-27
AU2020388532A1 (en) 2022-05-26
BR112022009082A2 (pt) 2022-07-26
JP2023503000A (ja) 2023-01-26

Similar Documents

Publication Publication Date Title
IL282746A (en) Enzyme and a new CRISPR/CAS12F system
PH12017501481B1 (en) Bicyclic heterocycles as fgfr inhibitors
PH12017500803A1 (en) Anti-pd-1 antibodies
MX2020003939A (es) Inhibidores de mdm2 y metodos terapeuticos que utilizan los mismos.
MY187486A (en) Cysteine protease
MY188696A (en) Cysteine protease
MX2020010951A (es) Anticuerpos anti-hla-g y utilizacion de los mismos.
MX2024001394A (es) Anticuerpos anti-bcma unicamente de cadena pesada.
MX2017009538A (es) Antigenos de citomegalovirus y su uso.
EP4275705A3 (en) Pancreatitis treatment
MX2019008872A (es) Prevencion y tratamiento de da?o o enfermedad osea y cartilago.
MX2019015563A (es) Anticuerpos anti-bcma unicamente de cadena pesada.
WO2019079520A3 (en) Variant icos ligand immunomodulatory proteins and related compositions and methods
MX2020004419A (es) Polipeptidos fhbp meningococicos modificados.
MX2016010173A (es) Metodos de tratamiento de enfermedad de alzheimer.
EA201992175A1 (ru) Композиции и способы, включающие пробиотические молекулы
MY191539A (en) Streptococcal vaccine
MX2018013742A (es) Formas cristalinas de crisaborol en forma libre, metodo de preparacion y uso de las mismas.
MX2019004487A (es) Metodos y composiciones para el tratamiento de la enfermedad de fabry.
ZA202211980B (en) Methods and treatment of trauma
MX2021008022A (es) Proteínas heterodiméricas para modular células t gamma delta.
MX2022000712A (es) Moduladores de nlrp3.
MX2020013389A (es) Composiciones de terlipresina y usos de las mismas.
MX2022004373A (es) Celulas madre modificadas y metodos de uso de las mismas.
MX2021008941A (es) Moduladores gpr35.